Clement Chen, former chief strategy officer at Leidos‘ (NYSE: LDOS) health group, has been appointed as CEO of DSFederal. His
The Food and Drug Administration has awarded DSFederal a potential $20 million contract to upgrade and maintain the agency’s Safety Reporting Portal. SRP
